BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9431844)

  • 1. Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
    Li A; Li KX; Marui S; Krozowski ZS; Batista MC; Whorwood CB; Arnhold IJ; Shackleton CH; Mendonca BB; Stewart PM
    J Hypertens; 1997 Dec; 15(12 Pt 1):1397-402. PubMed ID: 9431844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.
    Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM
    Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.
    Stewart PM; Krozowski ZS; Gupta A; Milford DV; Howie AJ; Sheppard MC; Whorwood CB
    Lancet; 1996 Jan; 347(8994):88-91. PubMed ID: 8538347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic defect resulting in mild low-renin hypertension.
    Wilson RC; Dave-Sharma S; Wei JQ; Obeyesekere VR; Li K; Ferrari P; Krozowski ZS; Shackleton CH; Bradlow L; Wiens T; New MI
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10200-5. PubMed ID: 9707624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
    Nunez BS; Rogerson FM; Mune T; Igarashi Y; Nakagawa Y; Phillipov G; Moudgil A; Travis LB; Palermo M; Shackleton C; White PC
    Hypertension; 1999 Oct; 34(4 Pt 1):638-42. PubMed ID: 10523339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
    Carvajal CA; Gonzalez AA; Romero DG; González A; Mosso LM; Lagos ET; Hevia Mdel P; Rosati MP; Perez-Acle TO; Gomez-Sanchez CE; Montero JA; Fardella CE
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2501-7. PubMed ID: 12788846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
    Kitanaka S; Katsumata N; Tanae A; Hibi I; Takeyama K; Fuse H; Kato S; Tanaka T
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4054-8. PubMed ID: 9398712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene.
    Lavery GG; Ronconi V; Draper N; Rabbitt EH; Lyons V; Chapman KE; Walker EA; McTernan CL; Giacchetti G; Mantero F; Seckl JR; Edwards CR; Connell JM; Hewison M; Stewart PM
    Hypertension; 2003 Aug; 42(2):123-9. PubMed ID: 12860834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC
    Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent Mineralocorticoid Excess in the Pediatric Population: Report of a Novel Pathogenic Variant of the 11β-HSD2 Gene and Systematic Review of the Literature.
    Adamidis A; Cantas-Orsdemir S; Tsirka A; Abbott MA; Visintainer P; Tonyushkina K
    Pediatr Endocrinol Rev; 2019 Mar; 16(3):335-358. PubMed ID: 30888125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
    Hatakeyama H; Inaba S; Miyamori I
    Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population.
    Quinkler M; Bappal B; Draper N; Atterbury AJ; Lavery GG; Walker EA; DeSilva V; Taylor NF; Hala S; Rajendra N; Stewart PM
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):143-9. PubMed ID: 15134813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic, biochemical, and clinical studies of patients with A328V or R213C mutations in 11betaHSD2 causing apparent mineralocorticoid excess.
    Morineau G; Marc JM; Boudi A; Galons H; Gourmelen M; Corvol P; Pascoe L; Fiet J
    Hypertension; 1999 Sep; 34(3):435-41. PubMed ID: 10489390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
    Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.